On ECHEMI
Home > Drugs > Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
Beijing Haiwang Zhongxin Pharmaceutical Co., Ltd.
  • Founded in:

    1990-08-14
  • Country:

    China China
  • Address:

    No. 1, Qiangyun Road, Economic Development Zone, Miyun District, Beijing
  • Tax NO.:

    91110228102644755T
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

Related Drugs
Triple Calcium Chewable Tablets
This product is a compound preparation. Each tablet contains 0.05 g of calcium lactate, calcium gluconate, and calcium hydrogen phosphate (equivalent to a total calcium content of 22.6 mg).
Name Description Content CAS NO. Registered Holders
Calcium lactate

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

0.05g 814-80-2 10
CALCIUM GLUCONATE MONOHYDRATE

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

0.05g 66905-23-5 35
Calcium phosphate dibasic

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

More

Participates in bone formation and reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism, and can reduce the permeability of capillaries, etc.

0.05g 7757-93-9 16
Kitasamycin Tablets
Kitasamycin
Name Description Content CAS NO. Registered Holders
Sineptina

This product is a macrolide antibiotic. Its mechanism of action is similar to that of erythromycin, and its antibacterial spectrum is also similar to that of erythromycin, but its antibacterial activity against most Gram-positive bacteria is slightly worse. Some erythromycin-resistant Staphylococcus aureus are still sensitive to kitasamycin. This product also has considerable activity against diphtheria, tetani, Neisseria gonorrhoeae, pertussis, Rickettsia and Chlamydia trachomatis.

More

This product is a macrolide antibiotic. Its mechanism of action is similar to that of erythromycin, and its antibacterial spectrum is also similar to that of erythromycin, but its antibacterial activity against most Gram-positive bacteria is slightly worse. Some erythromycin-resistant Staphylococcus aureus are still sensitive to kitasamycin. This product also has considerable activity against diphtheria, tetani, Neisseria gonorrhoeae, pertussis, Rickettsia and Chlamydia trachomatis.

1392-21-8 8
Benaciclib Methylbromide Tablets
The main ingredient of this product is benatyl bromide
Name Description Content CAS NO. Registered Holders
Methylbenactyzine bromide

Anticholinergic drugs, with atropine and papaverine-like effects. This product has the effects of relieving spasms and resisting gastric acid secretion, and can make gastrointestinal function tend to normal; this product can also inhibit sweat gland secretion, so it can be used to treat hyperhidrosis.

More

Anticholinergic drugs, with atropine and papaverine-like effects. This product has the effects of relieving spasms and resisting gastric acid secretion, and can make gastrointestinal function tend to normal; this product can also inhibit sweat gland secretion, so it can be used to treat hyperhidrosis.

3166-62-9 4
Sulpiride Tablets
The main ingredient of this product is Sulpiride, and its chemical name is: N-[methyl-(1-ethyl-2-pyrrolidinyl)]-2-methoxy-5-aminosulfonyl)-benzamide.
Name Description Content CAS NO. Registered Holders
Sulpiride

This product belongs to the benzamide antipsychotic drug, and its characteristic is to selectively block the dopamine (DA2) receptors of the midbrain limbic system, with little effect on other neurotransmitter receptors, mild anticholinergic effect, and no obvious sedative and anti-excitement and agitation effects. This product also has strong antiemetic and gastric secretion inhibition effects

More

This product belongs to the benzamide antipsychotic drug, and its characteristic is to selectively block the dopamine (DA2) receptors of the midbrain limbic system, with little effect on other neurotransmitter receptors, mild anticholinergic effect, and no obvious sedative and anti-excitement and agitation effects. This product also has strong antiemetic and gastric secretion inhibition effects

15676-16-1 11
Indomethacin Enteric-coated Tablets
The main ingredients of this product and their chemical names are: The main ingredient of this product is indomethacin, and its chemical name is 2-methyl-1-(4-chlorobenzoyl)-5-methoxy-1H-indole-3-acetic acid.
Name Description Content CAS NO. Registered Holders
Indometacin

It has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase. It stops the formation of pain nerve impulses in inflammatory tissues and inhibits inflammatory reactions, including inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes. As for the antipyretic effect, it acts on the hypothalamic temperature regulation center, causing peripheral vasodilation and sweating, which increases heat dissipation. This central antipyretic effect may also be related to the inhibition of prostaglandin synthesis in the hypothalamus.

More

It has anti-inflammatory, antipyretic and analgesic effects. Its mechanism of action is to reduce the synthesis of prostaglandins by inhibiting cyclooxygenase. It stops the formation of pain nerve impulses in inflammatory tissues and inhibits inflammatory reactions, including inhibiting the chemotaxis of leukocytes and the release of lysosomal enzymes. As for the antipyretic effect, it acts on the hypothalamic temperature regulation center, causing peripheral vasodilation and sweating, which increases heat dissipation. This central antipyretic effect may also be related to the inhibition of prostaglandin synthesis in the hypothalamus.

53-86-1 23
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.